CD70 and glioblastoma: CD70, a member of the tumor necrosis factor superfamily and ligand for CD27, is overexpressed in renal cell carcinoma, leukemia, non-small cell lung cancer, melanoma, and GBM [45, 144], where its high expression is strongly correlated with reduced patient survival [145].